Correlation Between Cullinan Oncology and Biomea Fusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Biomea Fusion, you can compare the effects of market volatilities on Cullinan Oncology and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Biomea Fusion.

Diversification Opportunities for Cullinan Oncology and Biomea Fusion

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Cullinan and Biomea is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Biomea Fusion go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Biomea Fusion

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.79 times more return on investment than Biomea Fusion. However, Cullinan Oncology LLC is 1.27 times less risky than Biomea Fusion. It trades about -0.27 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.46 per unit of risk. If you would invest  1,692  in Cullinan Oncology LLC on August 30, 2024 and sell it today you would lose (383.00) from holding Cullinan Oncology LLC or give up 22.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  Biomea Fusion

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Biomea Fusion 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Biomea Fusion is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cullinan Oncology and Biomea Fusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and Biomea Fusion

The main advantage of trading using opposite Cullinan Oncology and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.
The idea behind Cullinan Oncology LLC and Biomea Fusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets